Cargando…

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome

The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of infection with specific pathogens. Serum samples from...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloupenska, Kristyna, Dolezilkova, Jana, Koubkova, Barbora, Hutyrova, Beata, Racansky, Mojmir, Horak, Pavel, Golovchenko, Maryna, Raska, Milan, Rudenko, Natalie, Krupka, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619037/
https://www.ncbi.nlm.nih.gov/pubmed/34835343
http://dx.doi.org/10.3390/microorganisms9112217
_version_ 1784604892641361920
author Sloupenska, Kristyna
Dolezilkova, Jana
Koubkova, Barbora
Hutyrova, Beata
Racansky, Mojmir
Horak, Pavel
Golovchenko, Maryna
Raska, Milan
Rudenko, Natalie
Krupka, Michal
author_facet Sloupenska, Kristyna
Dolezilkova, Jana
Koubkova, Barbora
Hutyrova, Beata
Racansky, Mojmir
Horak, Pavel
Golovchenko, Maryna
Raska, Milan
Rudenko, Natalie
Krupka, Michal
author_sort Sloupenska, Kristyna
collection PubMed
description The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of infection with specific pathogens. Serum samples from 103 patients with suspected post-treatment Lyme disease syndrome were tested for the presence of antibodies to the major tick-borne pathogens Anaplasma phagocytophilum, Bartonella henselae/Bartonella quinatana, and Babesia microti. Although the presence of anti-Anaplasma antibodies was detected in 12.6% of the samples and anti-Bartonella antibodies in 9.7% of the samples, the presence of antibodies against both pathogens in the same samples or anti-Babesia antibodies in the selected group of patients could not be confirmed. However, we were able to detect autoantibodies, mostly antinuclear, in 11.6% of the patients studied. Our results are in good agreement with previously published studies showing the presence of a wide spectrum of autoantibodies in some patients with complicated forms of Lyme disease and post-treatment Lyme disease syndrome, but they do not reveal a significant influence of co-infections on the development of PTLDS in the studied group of patients.
format Online
Article
Text
id pubmed-8619037
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86190372021-11-27 Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome Sloupenska, Kristyna Dolezilkova, Jana Koubkova, Barbora Hutyrova, Beata Racansky, Mojmir Horak, Pavel Golovchenko, Maryna Raska, Milan Rudenko, Natalie Krupka, Michal Microorganisms Article The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of infection with specific pathogens. Serum samples from 103 patients with suspected post-treatment Lyme disease syndrome were tested for the presence of antibodies to the major tick-borne pathogens Anaplasma phagocytophilum, Bartonella henselae/Bartonella quinatana, and Babesia microti. Although the presence of anti-Anaplasma antibodies was detected in 12.6% of the samples and anti-Bartonella antibodies in 9.7% of the samples, the presence of antibodies against both pathogens in the same samples or anti-Babesia antibodies in the selected group of patients could not be confirmed. However, we were able to detect autoantibodies, mostly antinuclear, in 11.6% of the patients studied. Our results are in good agreement with previously published studies showing the presence of a wide spectrum of autoantibodies in some patients with complicated forms of Lyme disease and post-treatment Lyme disease syndrome, but they do not reveal a significant influence of co-infections on the development of PTLDS in the studied group of patients. MDPI 2021-10-25 /pmc/articles/PMC8619037/ /pubmed/34835343 http://dx.doi.org/10.3390/microorganisms9112217 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sloupenska, Kristyna
Dolezilkova, Jana
Koubkova, Barbora
Hutyrova, Beata
Racansky, Mojmir
Horak, Pavel
Golovchenko, Maryna
Raska, Milan
Rudenko, Natalie
Krupka, Michal
Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title_full Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title_fullStr Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title_full_unstemmed Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title_short Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
title_sort seroprevalence of antibodies against tick-borne pathogens in czech patients with suspected post-treatment lyme disease syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619037/
https://www.ncbi.nlm.nih.gov/pubmed/34835343
http://dx.doi.org/10.3390/microorganisms9112217
work_keys_str_mv AT sloupenskakristyna seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT dolezilkovajana seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT koubkovabarbora seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT hutyrovabeata seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT racanskymojmir seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT horakpavel seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT golovchenkomaryna seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT raskamilan seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT rudenkonatalie seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome
AT krupkamichal seroprevalenceofantibodiesagainsttickbornepathogensinczechpatientswithsuspectedposttreatmentlymediseasesyndrome